Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros

País como assunto
Tipo de documento
Intervalo de ano de publicação
1.
Environ Sci Technol ; 55(12): 8203-8214, 2021 06 15.
Artigo em Inglês | MEDLINE | ID: mdl-34081443

RESUMO

Air pollution exposure is a risk factor for arrhythmia. The atrioventricular (AV) conduction axis is key for the passage of electrical signals to ventricles. We investigated whether environmental nanoparticles (NPs) reach the AV axis and whether they are associated with ultrastructural cell damage. Here, we demonstrate the detection of the shape, size, and composition of NPs by transmission electron microscopy (TEM) and energy-dispersive X-ray spectrometry (EDX) in 10 subjects from Metropolitan Mexico City (MMC) with a mean age of 25.3 ± 5.9 and a 71-year-old subject without cardiac pathology. We found that in every case, Fe, Ti, Al, Hg, Cu, Bi, and/or Si spherical or acicular NPs with a mean size of 36 ± 17 nm were present in the AV axis in situ, freely and as conglomerates, within the mitochondria, sarcomeres, lysosomes, lipofuscin, and/or intercalated disks and gap junctions of Purkinje and transitional cells, telocytes, macrophages, endothelium, and adjacent atrial and ventricular fibers. Erythrocytes were found to transfer NPs to the endothelium. Purkinje fibers with increased lysosomal activity and totally disordered myofilaments and fragmented Z-disks exhibited NP conglomerates in association with gap junctions and intercalated disks. AV conduction axis pathology caused by environmental NPs is a plausible and modifiable risk factor for understanding common arrhythmias and reentrant tachycardia. Anthropogenic, industrial, e-waste, and indoor NPs reach pacemaker regions, thereby increasing potential mechanisms that disrupt the electrical impulse pathways of the heart. The cardiotoxic, oxidative, and abnormal electric performance effects of NPs in pacemaker locations warrant extensive research. Cardiac arrhythmias associated with nanoparticle effects could be preventable.


Assuntos
Resíduo Eletrônico , Mercúrio , Nanopartículas , Taquicardia por Reentrada no Nó Atrioventricular , Idoso , Arritmias Cardíacas/induzido quimicamente , Nó Atrioventricular , Humanos , Resíduos Industriais , México , Titânio
2.
Rev Invest Clin ; 64(2): 173-81, 2012.
Artigo em Espanhol | MEDLINE | ID: mdl-22991779

RESUMO

OBJECTIVES: A longitudinal, randomized, single blind study was done to evaluate the efficacy of an antibacterial hybrid molecule (beta-lactamic-fluoroquinolone) named cephalone after biliary-enteric-bypass (BEB). MATERIAL AND METHODS: Four groups of mongrel dogs were operated on three consecutive periods. Cultures of bile and liver were obtained and assessed, followed by obliteration of common bile duct and BEB to groups A, B and C. Group D served as a control. Ten days later the group A received conventional treatment based on ampicillin/gentamicin and groups B and C, cephalone in two different concentration schemes during 10 consecutive days. Further samples were processed for bacteria and additional liver biopsies were obtained for histopathological analysis. RESULTS: All three treatments reverted bacterial contamination in the liver and most of the bile samples were negative or showed a significant decrease in the number of colony forming units (p = 0.002). Histopathological analysis proved no lesions. CONCLUSIONS: Comparison of efficacy among antibacterial treatments revealed undistinguishable efficacy in this short-term assessment of bacterial contamination after BEB in dogs. The use of cephalone could be considered as a viable treatment or prophylaxis in bacterial infections occurring after BEB. Further studies are needed to assess long-term impact of the cephalone in this setting.


Assuntos
Antibacterianos/uso terapêutico , Infecções Bacterianas/tratamento farmacológico , Bile/microbiologia , Cefalosporinas/uso terapêutico , Fluoroquinolonas/uso terapêutico , Fígado/microbiologia , Animais , Modelos Animais de Doenças , Cães , Combinação de Medicamentos , Feminino , Masculino
3.
Vet Rec Open ; 5(1): e000238, 2018.
Artigo em Inglês | MEDLINE | ID: mdl-29632670

RESUMO

The aim of this study was to describe the tracheal growth pattern and its zoometric relationship in related medium-sized mongrel puppies through adulthood. Fourteen puppies were studied. CT monitoring was performed monthly, starting in the 1st month of life through the 7th month and subsequently at the 9th and 12th months. Additionally, six zoometric measurements were performed. Dorsoventral (DV) and transverse (TV) diameters and the luminal area from C1 to T2 were obtained. The global tracheal growth pattern revealed an increase up to 13 times its initial size, reaching a plateau phase during the last trimester. The relationship between the DV and the TV internal diameters of the tracheal lumen did not change during growth. As previously reported, the cranial tracheal area was wider, while the caudal part gradually decreased towards T1-T2; this consideration is important since the more distal an endotracheal tube is inserted, the greater the risk that injury may occur. The linear correlation between the zoometric measurements and the tracheal ring areas was positive. This study provides evidence for the evaluation of the morphometry of the canine trachea during physiological growth using helicoidal CT as a non-invasive, accurate tool.

4.
Int. j. morphol ; 32(2): 531-536, jun. 2014. ilus
Artigo em Espanhol | LILACS | ID: lil-714304

RESUMO

La encefalopatía por hipoxia es causa de discapacidad y requiere de nuevas estrategias terapéuticas. El pirofosfato de tiamina (PPT) es un cofactor esencial de enzimas fundamentales en el metabolismo de la glucosa, cuya disminución puede conducir a la falla en la síntesis de ATP y a la muerte celular. El objetivo de este estudio fue determinar si la administración de PPT, puede reducir el daño celular en un modelo de hipoxia neonatal en ratas. Animales de 11 días de edad fueron tratados con PPT (130 mg/kg) en dosis única o solución salina, una hora antes del protocolo de hipoxia o al término de ésta. Los cerebros fueron colectados para la evaluación del daño celular. Además, se tomaron muestras sanguíneas para evaluar los indicadores gasométricos de presión de dióxido de carbono (PaCO2) y de oxígeno (PaO2) en sangre arterial y pH. Los resultados muestran que la administración de PPT previa a la inducción de hipoxia, reduce el daño celular y restablece los indicadores gasométricos. Estos datos indican que el uso de PPT reduce el daño inducido por la hipoxia en animales neonatos.


Hypoxic encephalopathy is a leading cause of disability and requires new therapeutic strategies. Thiamine pyrophosphate (TPP) is an essential cofactor of fundamental enzymes involved in glucose metabolism. TPP reduction may lead to ATP synthesis failure and cell death. The objective of this study was to determine if TPP administration can reduce cellular damage in a model of neonatal hypoxia in rats. Eleven day old animals were treated with TPP (130 mg/kg) as a single dose or with saline solution one hour before the hypoxia protocol or after ending the protocol. The brains were collected to evaluate cellular damage. Blood samples were also collected to evaluate arterial oxygen tension (PaO2), carbon dioxide tension (PaCO2) and acidity (pH). The results showed that TPP administration previous to hypoxia induction reduces cellular damage and reestablishes arterial blood gases. These data indicate that TPP use reduces the damage induced by hypoxia in neonatal animals.


Assuntos
Animais , Masculino , Ratos , Tiamina Pirofosfato/administração & dosagem , Apoptose/efeitos dos fármacos , Substâncias Protetoras/administração & dosagem , Hipóxia/tratamento farmacológico , Oxigênio/sangue , Tiamina Pirofosfato/farmacologia , Gasometria , Encefalopatias/prevenção & controle , Ratos Wistar , Substâncias Protetoras/farmacologia , Modelos Animais de Doenças , Concentração de Íons de Hidrogênio , Animais Recém-Nascidos
5.
Rev. gastroenterol. Méx ; Rev. gastroenterol. Méx;62(1): 14-21, ene.-mar. 1997. tab, ilus
Artigo em Espanhol | LILACS | ID: lil-214193

RESUMO

Antecedentes: El trasplante intestinal segmentario es una opción prometedora en el tratamiento del intestino corto letal; el injerto enteral proximal reditúa experimentalmente mejor control inmunológico pero su efectividad funcional respecto a otros segmentos podría ser deficiente. Objetivo: Con el propósito de evaluar la mortalidad quirúrgica y el comportamiento funcional de tres variantes de trasplantes segmentarios enterales, se llevó a cabo el siguiente experimento. Método: Se formaron aleatoriamente cinco grupos de ratas Lewis, singénicas, en fase de crecimiento; en cuatro de ellas se efectuaron enterectomías del 90 por ciento, simultáneamente se trasplantaron segmentos del 30 por ciento de intestino proximal, medial o distal en los tres primeros grupos y del 90 por ciento en el cuarto; el quinto grupo se usó como testigo. Resultados. Se efectuaron 54 trasplantes, un tercio presentó complicaciones tardías, sólo en la mitad de ellos se pudo encontrar causas susceptibles de ser controladas; las complicaciones se presentaron en proporciones similares en todos los grupos. A cuatro meses de realizados los injertos, ninguna rata de las sobrevivientes interrumpió el crecimiento, sin embargo el grupo de trasplante proximal presentó déficit ponderal respecto a los otros grupos P < 0.05; los grupos de trasplante medial, distal y total alcanzaron patrones de crecimientos similar a grupo testigo; los niveles plasmásticos de triglicéridos, colesterol y glucosa después de la prueba de la maltosa fueron similares en todos los grupos, únicamente se observaron niveles inferiores de albúmina en el grupo de trasplante proximal P < 0.05. Conclusiones: los trasplantes segmentarios medial y distal mostraron una mejor respuesta en término de incremento ponderal, comparables a la obtenida en sujetos con restitución total o integridad enteral


Assuntos
Animais , Ratos , Modelos Animais de Doenças , Intestinos/patologia , Intestinos/fisiologia , Intestinos/transplante
SELEÇÃO DE REFERÊNCIAS
Detalhe da pesquisa